117 related articles for article (PubMed ID: 36587427)
1. PDGFRβ targeted innovative imaging probe for pancreatic adenocarcinoma detection.
Gao X; Xu H; Ye Z; Chen X; Wang X; Chang Q; Gu Y
Talanta; 2023 Apr; 255():124225. PubMed ID: 36587427
[TBL] [Abstract][Full Text] [Related]
2. An Integrin-α
Zhao H; Gao H; Luo C; Yang G; Zhao X; Gao S; Ma Q; Jia B; Shi J; Wang F
Bioconjug Chem; 2021 Jul; 32(7):1298-1305. PubMed ID: 34137602
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma.
Li M; Wei W; Barnhart TE; Jiang D; Cao T; Fan K; Engle JW; Liu J; Chen W; Cai W
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2737-2748. PubMed ID: 33537836
[TBL] [Abstract][Full Text] [Related]
4. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
5. c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models.
Li D; Yang M; Liang M; Mei C; Lin Y; Yang F; Xiao Y; Chen Y; Wang F; Mao J; Su Z
Biomater Sci; 2021 Oct; 9(20):6737-6752. PubMed ID: 34254599
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Dai Y; Tang Y; Huang W; Zhao Y; Gao X; Gu Y
Talanta; 2022 Dec; 250():123715. PubMed ID: 35868149
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
[TBL] [Abstract][Full Text] [Related]
8. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
9. Application of near-infrared fluorescence imaging using a polymeric nanoparticle-based probe for the diagnosis and therapeutic monitoring of colon cancer.
Yoon SM; Myung SJ; Kim IW; Do EJ; Ye BD; Ryu JH; Park K; Kim K; Kwon IC; Kim MJ; Moon DH; Yang DH; Kim KJ; Byeon JS; Yang SK; Kim JH
Dig Dis Sci; 2011 Oct; 56(10):3005-13. PubMed ID: 21465144
[TBL] [Abstract][Full Text] [Related]
10. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.
Liu Z; Liu H; Ma T; Sun X; Shi J; Jia B; Sun Y; Zhan J; Zhang H; Zhu Z; Wang F
J Nucl Med; 2014 Jun; 55(6):989-94. PubMed ID: 24711651
[TBL] [Abstract][Full Text] [Related]
11. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
[TBL] [Abstract][Full Text] [Related]
12. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
13. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.
Carlesso FN; Fuscaldi LL; Araújo RS; Teixeira CS; Oliveira MC; Fernandes SO; Cassali GD; Reis DC; Barros AL; Cardoso VN
Braz J Med Biol Res; 2015 Oct; 48(10):923-8. PubMed ID: 26445336
[TBL] [Abstract][Full Text] [Related]
15. Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging.
Qi B; Crawford AJ; Wojtynek NE; Talmon GA; Hollingsworth MA; Ly QP; Mohs AM
Theranostics; 2020; 10(8):3413-3429. PubMed ID: 32206099
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
17. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232
[TBL] [Abstract][Full Text] [Related]
18. AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis.
Tu Y; Liu Z; Wang F; Liu P; Tao J; Li C; Han Z; Li Z; Ma Y; Gu Y
ACS Sens; 2020 Dec; 5(12):4072-4080. PubMed ID: 33232127
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
